Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented at Global Conference

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its novel blood test for oesophageal adenocarcinoma will be presented tomorrow at the 19th ISDE World Congress for Esophageal Diseases.

Related Keywords

Canada ,United States ,Australia ,Perth ,Western Australia ,Toronto ,Ontario ,Richard Lipscombe ,Proteomics International ,Progression Of Barrett Esophagus To Cancer Network ,Laboratory Developed Test ,Proteomics International Laboratories Ltd ,Summary Of The Diagnostic Test Development ,Us Laboratory Developed Test ,Economic Health Benefit ,Ochsner Health System ,International Society For Diseases Of The Esophagus ,World Congress ,Proteomics International Laboratories ,Esophageal Diseases ,Oesophageal Cancer Test Presented ,International Laboratories Ltd ,Key Opinion Leaders ,Victorian Cancer Biobank ,Developed Test ,Economic Health Benefit Modelling ,Clinical Utility Studies ,International Society ,Diagnostic Test Development ,Validation Study ,Cancer Network ,New Orleans ,Area Under ,Prostate Specific Antigen ,International Laboratories ,Biotech ,Health Pharm Generalproteomics International Laboratories Ltd ,Asx Piq ,